Skip to main content
painEvidence: Grade B

Using Your Joovv Go 2.0 for Neuropathy Treatment

Published: Last updated:

Device-specific protocol for Neuropathy using the Joovv Joovv Go 2.0 (660/850nm, 115 mW/cm²)

Your Joovv Go 2.0 Protocol for Neuropathy

Wavelengths

660nm, 850nm

Session Time

2 min

Target Dose

12 J/cm²

Distance

Direct contact to 3 inches

Frequency

3-5x/week

Timeline

4-12 weeks

Why Joovv Go 2.0 for Neuropathy?

The Joovv Joovv Go 2.0 emits at 660nm and 850nm, which provides a good match for Neuropathy treatment. Research for this condition recommends 830nm, 850nm.

At 115 mW/cm² irradiance (at the recommended distance of Direct contact to 3 inches), you'll need approximately 2 minutes per session to reach the target dose of 12 J/cm². This falls within the recommended range of 4-20 J/cm² for Neuropathy.

The Joovv Go 2.0 is a handheld device with targeted coverage. For Neuropathy, you may need to treat each area separately if the affected zone is larger than the device's coverage.

Joovv Go 2.0 Quick Specs

Price

$449

LEDs

18

Power

30W

FDA

Registered

Evidence for Neuropathy

Near-infrared therapy at 830-850nm shows encouraging results for diabetic peripheral neuropathy, with some studies reporting improved sensation and reduced pain scores. Dose: 4-20 J/cm², 15-30 minutes, 3-5x/week for 4-12 weeks. Evidence grade: B (moderate — small but consistent study results).

Same Condition, Different Devices

Research Basis

This content is informed by 47+ published peer-reviewed studies on photobiomodulation.